LivingGLP1
Study S000171

Does Personality Predict Patient Adherence, Health Behaviors, and Weight Loss Outcomes During the Latino Crossover Semaglutide Study (LCSS)? (Story-LCSS Project)

Registration

Registration
NCT05622045
Acronym
StoryLCSS
Study type
OBSERVATIONAL
Status
ACTIVE_NOT_RECRUITING
Enrollment
59
Start
2023-02-01
Primary completion
2024-05-29
Lead sponsor
Loma Linda University
Conditions
Obesity; Body Weight Changes
Interventions
BEHAVIORAL:Voice data
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • Predicted patient weight change success [The voice data measurement will take place at baseline and take about 10-15 minutes for collection to take place.]
  • Clinician predictions [The clinician judgement will be measured during the second month of the subject's weight loss study.]
  • Predicated patient calorie intake [The voice data measurement will take place during the subject's initial clinic visit and take about 10-15 minutes for collection to take place.]
  • Predicated patient physical activity level [The voice data measurement will take at baseline and take about 10-15 minutes for collection to take place.]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
RecordTitleYearDesignIdentifiersLink basis
R0023399Once-Weekly Semaglutide in Adults with Overweight or Obesity.
Wilding JPH, The New England journal of medicine
2021Randomized trialPMID 33567185DOIregistry reference BACKGROUND:33567185